GlassScriptPhysician profile
Conrad L Flick
NPI 1003949595
$2,786.67
in general payments reported to CMS, 2019-2025
37 companies · $546 in 2025
The $546 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $957 · 2020: $334 · 2021: $157 · 2023: $285 · 2024: $508 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $525.66 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $353.77 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $269.77 | 2019-2025 | Farxiga, Airsupra |
| Amgen INC. | $234.59 | 2019-2025 | Repatha, Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.30 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $103.54 | 2019-2020 | |
| Glaxosmithkline, LLC. | $101.03 | 2019-2025 | Shingrix, Arexvy |
| Pfizer INC. | $94.27 | 2020-2025 | |
| Astellas Pharma US INC | $92.24 | 2023-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $91.73 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $87.87 | 2023-2025 | Keveyis |
| Exact Sciences Corporation | $84.93 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $59.67 | 2020-2024 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $54.31 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $39.10 | 2019-2020 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrad Flick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.